Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Gaedigk

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
International Review of Psychiatry (Abingdon, England)|October 25, 2013
Complexities of CYP2D6 gene analysis and interpretationAndrea Gaedigk
Clinical Pharmacology and Therapeutics|July 30, 2019
Pharmacogenetics: Chasing PerfectionAndrea Gaedigk
Pharmacogenomics|November 4, 2022
CYP2C18: the orphan in the CYP2C familyPablo Zubiaur, Andrea Gaedigk
European Journal of Clinical Pharmacology|January 19, 2008
The CYP2D6 gene locus in South African Coloureds: unique allele distributions, novel alleles and gene arrangementsAndrea Gaedigk, Christa Coetsee
Therapeutic Advances in Drug Safety|January 11, 2018
Precision medicine: does ethnicity information complement genotype-based prescribing decisions?Rashmi R Shah, Andrea Gaedigk
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 24, 2006
Comments on Hoskins et al. [(2005) drug metab dispos 33:1564-1565]Andrea Gaedigk, J Steven Leeder
Pharmacogenomics|March 15, 2014
CYP2D6 and pharmacogenomics: where does future research need to focus? Part 1: technical aspectsAndrea Gaedigk, J Steven Leeder
Pharmacogenomics|August 2, 2014
CYP2D6 and pharmacogenomics: where does future research need to focus? Part 2: clinical aspectsJ Steven Leeder, Andrea Gaedigk
Clinical Pharmacology and Therapeutics|August 5, 2021
CYP2D6*9 and *41: Does the Activity Value Assigned to these Alleles Need to be Reduced to more Accurately Predict Phenotype?Laura B Ramsey, Andrea Gaedigk
European Journal of Clinical Pharmacology|September 18, 2008
Identification of a novel non-functional CYP2D6 allele, CYP2D6*69, in a Caucasian poor metabolizer individualAndrea Gaedigk, Dorothee Frank, Uwe Fuhr
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
International Review of Psychiatry (Abingdon, England)|October 25, 2013
Complexities of CYP2D6 gene analysis and interpretationAndrea Gaedigk
Clinical Pharmacology and Therapeutics|July 30, 2019
Pharmacogenetics: Chasing PerfectionAndrea Gaedigk
Pharmacogenomics|November 4, 2022
CYP2C18: the orphan in the CYP2C familyPablo Zubiaur, Andrea Gaedigk
European Journal of Clinical Pharmacology|January 19, 2008
The CYP2D6 gene locus in South African Coloureds: unique allele distributions, novel alleles and gene arrangementsAndrea Gaedigk, Christa Coetsee
Therapeutic Advances in Drug Safety|January 11, 2018
Precision medicine: does ethnicity information complement genotype-based prescribing decisions?Rashmi R Shah, Andrea Gaedigk
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 24, 2006
Comments on Hoskins et al. [(2005) drug metab dispos 33:1564-1565]Andrea Gaedigk, J Steven Leeder
Pharmacogenomics|March 15, 2014
CYP2D6 and pharmacogenomics: where does future research need to focus? Part 1: technical aspectsAndrea Gaedigk, J Steven Leeder
Pharmacogenomics|August 2, 2014
CYP2D6 and pharmacogenomics: where does future research need to focus? Part 2: clinical aspectsJ Steven Leeder, Andrea Gaedigk
Clinical Pharmacology and Therapeutics|August 5, 2021
CYP2D6*9 and *41: Does the Activity Value Assigned to these Alleles Need to be Reduced to more Accurately Predict Phenotype?Laura B Ramsey, Andrea Gaedigk
European Journal of Clinical Pharmacology|September 18, 2008
Identification of a novel non-functional CYP2D6 allele, CYP2D6*69, in a Caucasian poor metabolizer individualAndrea Gaedigk, Dorothee Frank, Uwe Fuhr
Pageof 21